Medicare Enrolled
Dr. James Rybak, M.D.
Urology Physician · Fairview Heights, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rybak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rybak?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rybak
Dr. James Rybak is an urology physician in Fairview Heights, IL, with 17 years of NPI registration. Based on federal Medicare data, Dr. Rybak performed 15,531 Medicare services across 3,178 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rybak received a total of $9,662 from 59 pharmaceutical and/or device companies across 356 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rybak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 5% volume in IL
$9,662 industry payments
Medicare Practice Summary
Medicare Utilization ↗15,531
Medicare services
Top 5% in IL for urology physician
3,178
Unique beneficiaries
$16
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~914 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
11,115 | $0 | $1 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,274 | $2 | $10 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
614 | $84 | $320 |
| Chronic care management, first 20 min/month This service covers the first 20 minutes of clinical staff time directed by a healthcare professional each calendar month to manage chronic conditions. |
444 | $49 | $127 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
339 | $64 | $254 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
303 | $8 | $15 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
243 | $7 | $38 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
167 | $175 | $721 |
| Chronic care management, additional 20 min/month This service covers an extra 20 minutes of clinical staff time directed by a healthcare professional for managing two or more chronic conditions each calendar month. |
144 | $37 | $96 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
123 | $80 | $263 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
109 | $119 | $417 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
83 | $5 | $12 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
73 | $6 | $52 |
| CT scan of abdomen and pelvis with contrast A CT scan of the abdomen and pelvis using contrast dye before and after administration to visualize internal structures. |
67 | $263 | $829 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
45 | $103 | $440 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
39 | $73 | $312 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
37 | $230 | $809 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
35 | $63 | $229 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
34 | $452 | $1,643 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
34 | $146 | $443 |
| Other procedure on male genital system A surgical or medical intervention performed on the male genital organs that does not fall under other specific categories. |
32 | $206 | $909 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
31 | $99 | $688 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
21 | $95 | $1,106 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
19 | $10 | $98 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
19 | $114 | $456 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
16 | $105 | $351 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
15 | $249 | $919 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
15 | $334 | $1,252 |
| CT scan of abdomen with and without contrast A CT scan of the abdomen performed both before and after the administration of contrast dye to provide detailed images of internal structures. |
14 | $175 | $804 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
14 | $26 | $101 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
13 | $130 | $507 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
75.2% medium
24.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,662
Total received (2018-2024)
Avg $1,380/year across 7 years
Top 17% in IL for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
59
Companies
356
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,198 (95.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$464 (4.8%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,427
2023
$935
2022
$1,064
2021
$1,383
2020
$511
2019
$2,986
2018
$1,354
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$257
Astellas Pharma US Inc
$229
UROGEN PHARMA, INC.
$157
ACCORD HEALTHCARE, INC.
$123
Sumitomo Pharma America, Inc.
$101
Myriad Genetic Laboratories, Inc.
$80
Endo USA, Inc.
$71
Bayer Healthcare Pharmaceuticals Inc.
$57
SUN PHARMACEUTICAL INDUSTRIES INC.
$56
Merck Sharp & Dohme LLC
$49
Ferring Pharmaceuticals Inc.
$46
Tolmar, Inc.
$38
Teleflex LLC
$35
Dendreon Pharmaceuticals LLC
$30
PROGENICS PHARMACEUTICALS, INC.
$28
ABBVIE INC.
$22
Novartis Pharmaceuticals Corporation
$20
Janssen Biotech, Inc.
$16
Endo Pharmaceuticals Inc.
$14
Top 3 companies account for 45.0% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$1,787
Astellas Pharma US Inc
$1,140
Janssen Biotech, Inc.
$536
Rochester Medical Corporation
$438
PROCEPT BioRobotics Corporation
$428
Teleflex LLC
$353
ACCORD HEALTHCARE, INC.
$350
Antares Pharma, Inc.
$300
Boston Scientific Corporation
$249
Ferring Pharmaceuticals Inc.
$237
C. R. Bard, Inc. & Subsidiaries
$230
Myriad Genetic Laboratories, Inc.
$229
Sumitomo Pharma America, Inc.
$221
Merck Sharp & Dohme LLC
$206
UROGEN PHARMA, INC.
$179
Endo Pharmaceuticals Inc.
$167
Merck Sharp & Dohme Corporation
$161
Bayer HealthCare Pharmaceuticals Inc.
$148
Allergan Inc.
$146
Myovant Sciences Inc.
$145
Olympus America Inc.
$129
Bayer Healthcare Pharmaceuticals Inc.
$125
Acerus Pharmaceuticals Corporation
$125
PFIZER INC.
$121
BOSTON SCIENTIFIC CORPORATION
$112
KARL STORZ Endoscopy-America
$90
TOLMAR Pharmaceuticals, Inc.
$86
AbbVie, Inc.
$78
Tolmar, Inc.
$76
Dendreon Pharmaceuticals LLC
$74
Endo USA, Inc.
$71
Travere Therapeutics, Inc.
$66
AstraZeneca Pharmaceuticals LP
$65
SUN PHARMACEUTICAL INDUSTRIES INC.
$56
Clarus Therapeutics Inc.
$55
UROVANT SCIENCES INC
$51
Progenics Pharmaceuticals, Inc.
$50
Avadel Specialty Pharmaceuticals, LLC
$46
180 Medical, Inc.
$44
ABBVIE INC.
$43
Palette Life Sciences, Inc.
$43
C. R. BARD, INC. & SUBSIDIARIES
$42
Allergan, Inc.
$30
PROGENICS PHARMACEUTICALS, INC.
$28
Janssen Pharmaceuticals, Inc
$27
Alnylam Pharmaceuticals Inc.
$27
ROCHESTER MEDICAL CORPORATION
$26
Retrophin, Inc.
$25
PALETTE LIFE SCIENCES, INC.
$24
Laborie Medical Technologies Corp.
$23
Photocure Inc
$21
ConvaTec Inc.
$20
Novartis Pharmaceuticals Corporation
$20
Cook Incorporated
$17
Mission Pharmacal Company
$17
UroGen Pharma, Inc.
$17
Cook Medical LLC
$15
MEDIVATION FIELD SOLUTIONS LLC
$13
Foundation Medicine, Inc.
$13
Top 3 companies account for 35.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · 0.30MM · 24/26 FR. · ADVANCE · AMS · AMS 700 CXR RTE KIT · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AQUACEL AG · AVEED · Androgel · BIPOLAR · BOTOX · BOTOX THERAPEUTIC · BRIDION · Bard Urinary Drainage Bag · CAMCEVI · COOK MEDICAL STENTS · CUTTING LOOP · Cook Medical Stents · Cysview · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · GEMTESA · GENERAL KIDNEY STONE DISEASE · GENERAL - KIDNEY STONE DISEASE · GENTLECATH · GIVLAARI · INLAY OPTIMA · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LYNPARZA · Lupron · Lupron Depot · MAGIC3 · MYRBETRIQ · Myrbetriq · NOCDURNA · Natesto · Noctiva · Nubeqa · ORGOVYX · Otrexup · PLUVICTO · PROLARIS · PROVENGE · PYLARIFY · Prolaris · REZUM · SPACEOAR · SpeediCath · TOVIAZ · TRADE PROMO: SPIES FLEXC · Thiola · UROLIFT · US DEFL · Uribel · UroLift · UroLift ATC System · UroLift System · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · YONSA · ZYTIGA · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
110
Per 100K population
43.2
County median income
$70,178
Nearest hospital
MEMORIAL HOSPITAL
4.1 mi
4.1 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rybak is a mixed practice specialist, with above-average Medicare volume (top 5% in IL), with low-engagement industry engagement in the top 17% of IL peers, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rybak experienced with contrast dye for imaging (iodine-based)?
Based on Medicare claims data, Dr. Rybak performed 11,115 contrast dye for imaging (iodine-based) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rybak receive payments from pharmaceutical companies?
Yes. Dr. Rybak received a total of $9,662 from 59 companies across 356 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rybak's costs compare to other urology physicians in Fairview Heights?
Dr. Rybak's average Medicare payment per service is $16. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rybak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fairview Heights
Browse urology physicians in Fairview Heights ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in IL
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in IL
Which IL urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology